Neuroimaging plays a pivotal role in understanding Alzheimer’s Disease and dementia by providing non-invasive methods to visualize brain structure and function. Techniques like MRI (Magnetic Resonance Imaging) reveal structural changes such as brain atrophy, a hallmark of Alzheimer’s. Functional MRI (fMRI) helps study brain activity patterns, highlighting areas affected by dementia-related cognitive decline. PET (Positron Emission Tomography) scans detect amyloid plaques and tau tangles, key pathological features in Alzheimer’s. These imaging tools aid in early diagnosis, tracking disease progression, and assessing treatment effectiveness. Advances in neuroimaging continue to refine our understanding of how Alzheimer’s alters the brain, offering hope for improved diagnostic accuracy and targeted therapeutic strategies.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States